G
GMED
Globus Med Inc
59.55
-1.05-1.73%After Hours: 59.04 -0.51 -0.86%16:21 09/08 EDT
OPEN/PREV CLOSE60.64/60.60
TODAY RANGE59.00-60.64
VOL722.80K
MARKET CAP8.04B
52 WEEK RANGE51.79-94.93
AVG VOL (3M)1.40M
% TURNOVER0.54%
TURNOVER--
P/E (TTM)22.98
% RANGE2.41%
EPS(TTM)2.591
P/E(FORWARD)17.36
P/B1.872
BVPS31.81
DIVIDEND--
P/S3.248
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP6.64B
SHARES OUTSTANDING135.06M
NEXT EARNINGS11/03-11/07
FREE FLOAT111.52M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·08/29 15:07
Globus Medical wins favorable jury verdict in patent dispute with Life Spine
TipRanks·08/28 20:35
Globus Medical secures jury verdict in patent litigation against Life Spine
Dow Jones·08/28 20:31
*Globus Medical: Delaware Jury Awards Both Lost Profits, Reasonable Royalty Damages
NASDAQ·08/27 12:29
SP Platform's 88% Procedure Growth: The Next Frontier for ISRG?
TipRanks·08/20 11:55
Citizens JMP Remains a Hold on Globus Medical (GMED)
Seeking Alpha·08/19 09:38
Macquarie Small Cap Value Fund Q2 2025 Commentary
Benzinga·08/18 18:25
Carlsmed's Personalized Spine Implants Get Significant Reimbursement Advantage
Simply Wall St·08/16 06:02
Globus Medical’s Strong Q2 and Buyback Might Change The Case For Investing In GMED
TipRanks·08/14 12:25
Morgan Stanley Keeps Their Buy Rating on Globus Medical (GMED)
NASDAQ·08/14 11:22
Analysts Anticipate FNY Will Reach $96
NASDAQ·08/13 12:22
Globus Medical Stock Up on Q2 Earnings & Revenue Beat, Margins Expand
TipRanks·08/13 00:21
Globus Medical’s Earnings Call Highlights Robust Growth and Strategic Advances
Simply Wall St·08/12 05:54
Globus Medical (GMED) Is Up 10.8% After Strong Q2 Earnings and Maintained 2025 Outlook
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.